NYSE · MCO

Moody's Corporation

$485.96 +$14.46 (+3.07%) 1D After hours
Session Pulse Overnight session 1 mentions on Wed No new SEC filings since Mon close its sector ranked 9/11 this week Full pulse →

Key Metrics

$81.65B
Market cap
32.73×
P/E · TTM
$7.87B
Revenue · TTM
$2.50B
Net income
EPS · TTM $13.81
Dividend yield 0.8%
Free cash flow $2.75B
Beta · 1Y 0.57
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 22
    A material event was filed (Form 8-K).

    8-K - MOODYS CORP /DE/ (0001059556) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 3
    The stock moved -8.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$81.65B
Enterprise value$87.01B
Shares outstanding173.2M
52-wk range$402.28 – $546.88
Avg volume · 20D805.5K
Net cash −$5.35B
Book value / share$16.57
IndustryServices-Consumer Credit Reporting, Collection Agencies
ExchangeNYSE
About Moody's Corporation
IPO dateNov 5, 1984
Employees5300

Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed-income securities. The ratings segment, Moody's Investors Service, includes corporates, structured finance, financial institutions, and public finance ratings.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E32.73
P/S10.37
P/FCF29.73
EV/EBITDA
EV/Sales11.05
Graham №$71.75

Profitability

Gross
Operating 40.6%
Net 31.7%
FCF 34.9%
ROE / ROIC 76.1% · 29.6%

Financial Health

Current ratio1.16
Quick ratio
Debt / equity2.33
Debt / EBITDA
Net cash −$5.35B
Working capital$571.00M

Cash Flow · TTM

Operating CF $3.08B
Capex −$336.00M
Free cash flow $2.75B
Buybacks $2.71B
Dividends paid $691.00M
Shareholder yield 4.2%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

7.3
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$71.75 vs $485.96
Trades 6.8× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings